Melarsoprol refractory <em>T. b. gambiense</em> from Omugo, north-western Uganda (Publications)
Culture adapted T. b. gambiense isolated from Northwest Uganda were exposed to 0.001-0.14 microg/ml melarsoprol or 1.56-100 microg/ml DL-alpha-difluoromethylornithine (DFMO). Minimum inhibitory concen
A nucleoside transporter from <em>Trypanosoma brucei</em> involved in drug resistance (Publications)
Drug resistance of pathogens is an increasing problem whose underlying mechanisms are not fully understood. Cellular uptake of the major drugs against Trypanosoma brucei spp., the causative agents of
Ökonomische Nutzen und Kosten populationsbezogener Prävention und Gesundheitsförderung (Publications)
Objectives: It is a generally accepted requirement that disease and accident prevention as well as health promotion should be both effective and accomplished at minimum cost. The aim of this study is
Placental infection with <em>Plasmodium vivax</em>: a histopathological and molecular study (Publications)
Background. Evidence of the presence of Plasmodium vivax in the placenta is scarce and inconclusive. This information is relevant to understanding whether P. vivax affects placental function and how i
Development and validation of the Kilifi epilepsy beliefs and attitude scale (Publications)
Epilepsy remains misunderstood, particularly in resource poor countries (RPC). We developed and validated a tool to assess beliefs and attitudes about epilepsy among people with epilepsy (PWE) in Kili
Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancer (Publications)
The purpose of our study was to demonstrate that distinct cytogenetic alterations in the most common subtype of renal cell cancer, clear cell renal cell carcinoma (ccRCC), are reflected in protein exp
Efficacy of the novel diamidine compound 2,5-Bis(4-amidinophenyl)- furan-bis-<em>O</em>-Methlylamidoxime (Pafuramidine, DB289) against <em>Trypanosoma... (Publications)
Owing to the lack of oral drugs for human African trypanosomiasis, patients have to be hospitalized for 10 to 30 days to facilitate treatment with parenterally administered medicines. The efficacy of